FDA Orange Book · active-ingredient family
Amino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic
Amino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:AMINOSYN 8.5% W/ELECTROLYTES · NDA 017673
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| AMINOSYN 8.5% W/ELECTROLYTES | ICU MEDICAL INC | NDA 017673 | — | Oct 25, 2002 | |
| AMINOSYN II 8.5% W/ELECTROLYTES | ICU MEDICAL INC | NDA 019437 | — | Oct 25, 2002 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Amino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
